|
Market Closed -
Other stock markets
|
After hours 06:01:51 pm | |||
| 237.03 USD | -2.72% |
|
237.29 | +0.11% |
| Fiscal Period: January | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 21.25B | 26.49B | 31.35B | 34.86B | 37.9B | |||||
Total Revenues | 21.25B | 26.49B | 31.35B | 34.86B | 37.9B | |||||
Cost of Goods Sold, Total | 5.44B | 7.03B | 8.36B | 8.54B | 8.64B | |||||
Gross Profit | 15.81B | 19.47B | 22.99B | 26.32B | 29.25B | |||||
Selling General & Admin Expenses, Total | 11.76B | 14.4B | 16.08B | 15.41B | 16.09B | |||||
R&D Expenses | 3.6B | 4.46B | 5.06B | 4.91B | 5.49B | |||||
Other Operating Expenses, Total | 15.36B | 18.86B | 21.13B | 20.32B | 21.59B | |||||
Operating Income | 455M | 602M | 1.86B | 6B | 7.67B | |||||
Interest Expense, Total | -126M | -220M | -287M | -29M | -300M | |||||
Interest And Investment Income | - | - | - | - | 647M | |||||
Net Interest Expenses | -126M | -220M | -287M | -29M | 347M | |||||
Currency Exchange Gains (Loss) | - | - | - | - | - | |||||
Other Non Operating Income (Expenses) | 62M | -7M | 156M | 245M | 7M | |||||
EBT, Excl. Unusual Items | 391M | 375M | 1.73B | 6.22B | 8.02B | |||||
Restructuring Charges | - | - | -828M | -988M | -461M | |||||
Merger & Related Restructuring Charges | - | -54M | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 2.17B | 1.21B | -239M | -277M | -121M | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 2.56B | 1.53B | 660M | 4.95B | 7.44B | |||||
Income Tax Expense | -1.51B | 88M | 452M | 814M | 1.24B | |||||
Earnings From Continuing Operations | 4.07B | 1.44B | 208M | 4.14B | 6.2B | |||||
Net Income to Company | 4.07B | 1.44B | 208M | 4.14B | 6.2B | |||||
Net Income - (IS) | 4.07B | 1.44B | 208M | 4.14B | 6.2B | |||||
Net Income to Common Incl Extra Items | 4.07B | 1.44B | 208M | 4.14B | 6.2B | |||||
Net Income to Common Excl. Extra Items | 4.07B | 1.44B | 208M | 4.14B | 6.2B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 4.48 | 1.51 | 0.21 | 4.25 | 6.44 | |||||
Basic EPS - Continuing Operations | 4.48 | 1.51 | 0.21 | 4.25 | 6.44 | |||||
Basic Weighted Average Shares Outstanding | 908M | 955M | 992M | 974M | 962M | |||||
Net EPS - Diluted | 4.38 | 1.48 | 0.21 | 4.2 | 6.36 | |||||
Diluted EPS - Continuing Operations | 4.38 | 1.48 | 0.21 | 4.2 | 6.36 | |||||
Diluted Weighted Average Shares Outstanding | 930M | 974M | 997M | 984M | 974M | |||||
Normalized Basic EPS | 0.27 | 0.25 | 1.09 | 3.99 | 5.21 | |||||
Normalized Diluted EPS | 0.26 | 0.24 | 1.08 | 3.95 | 5.15 | |||||
Dividend Per Share | - | - | - | - | 1.6 | |||||
Payout Ratio | - | - | - | - | 24.8 | |||||
American Depositary Receipts Ratio (ADR) | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |||||
Supplemental Items | ||||||||||
EBITDA | 3.12B | 3.06B | 5.44B | 9.22B | 11.14B | |||||
EBITA | 1.38B | 1.37B | 3.65B | 7.16B | 9.32B | |||||
EBIT | 455M | 602M | 1.86B | 6B | 7.67B | |||||
EBITDAR | 4.33B | 4.14B | 6.42B | 10.26B | 11.83B | |||||
Total Revenues (As Reported) | 21.25B | 26.49B | 31.35B | 34.86B | 37.9B | |||||
Effective Tax Rate - (Ratio) | -59 | 5.74 | 68.48 | 16.44 | 16.68 | |||||
Current Domestic Taxes | 41M | -10M | 389M | 1.14B | 1.53B | |||||
Current Foreign Taxes | 238M | 352M | 397M | 417M | 925M | |||||
Total Current Taxes | 279M | 342M | 786M | 1.56B | 2.45B | |||||
Deferred Domestic Taxes | 294M | -238M | -337M | -822M | -1.15B | |||||
Deferred Foreign Taxes | -2.08B | -16M | 3M | 80M | -64M | |||||
Total Deferred Taxes | -1.79B | -254M | -334M | -742M | -1.21B | |||||
Normalized Net Income | 244M | 234M | 1.08B | 3.88B | 5.01B | |||||
Interest on Long-Term Debt | 125M | 221M | 297M | 29M | 300M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 787M | 1B | 1B | 1.1B | 1B | |||||
Selling and Marketing Expenses | 9.67B | 11.86B | 13.53B | 12.88B | 13.26B | |||||
General and Administrative Expenses | 2.09B | 2.54B | 2.55B | 2.53B | 2.84B | |||||
Research And Development Expense From Footnotes | 3.6B | 4.46B | 5.06B | 5.64B | 5.49B | |||||
Net Rental Expense, Total | 1.21B | 1.08B | 986M | 1.04B | 684M | |||||
Imputed Operating Lease Interest Expense | 192M | 183M | 155M | 16.98M | 128M | |||||
Imputed Operating Lease Depreciation | 1.02B | 897M | 831M | 1.02B | 556M | |||||
Stock-Based Comp., COGS (Total) | 241M | 386M | 499M | 431M | 518M | |||||
Stock-Based Comp., R&D Exp. (Total) | 703M | 918M | 1.14B | 972M | 1.09B | |||||
Stock-Based Comp., S&M Exp. (Total) | 941M | 1.1B | 1.26B | 1.06B | 1.2B | |||||
Stock-Based Comp., G&A Exp. (Total) | 305M | 371M | 368M | 299M | 367M | |||||
Stock-Based Comp., Other (Total) | - | - | 20M | 23M | 2M | |||||
Total Stock-Based Compensation | 2.19B | 2.78B | 3.28B | 2.79B | 3.18B |
- Stock Market
- Equities
- CRM Stock
- Financials Salesforce, Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















